1.
Anaesthesia
; 78(11): 1418-1419, 2023 11.
Article
in English
| MEDLINE
| ID: mdl-37329129
2.
Anaesthesia
; 73(8): 1008-1018, 2018 Aug.
Article
in English
| MEDLINE
| ID: mdl-29529345
ABSTRACT
Sodium-glucose co-transporter 2 (SGLT2) inhibitors are an emerging class of oral hypoglycaemic agents with therapeutic benefits beyond better glycaemic control. A major concern of the sodium-glucose co-transporter 2 inhibitors is their propensity to cause euglycaemic ketoacidosis in the peri-operative period and the potential for this critical diagnosis to be delayed or missed entirely. This review attempts to collate the case reports of sodium-glucose co-transporter 2 inhibitor ketoacidosis associated with surgery to highlight and put a perspective on this peri-operative issue. Preventive strategies and the management of the ketoacidosis are discussed.